scholarly journals The role of family history and its influence on the onset time in female pattern hair loss

2020 ◽  
Author(s):  
Adriana Łukasik ◽  
Karolina Kozicka ◽  
Agata Kłosowicz ◽  
Andrzej Jaworek ◽  
Anna Wojas-Pelc
Keyword(s):  
Family History ◽  
Hair Loss ◽  
Onset Time ◽  
Female Pattern Hair Loss

scholarly journals Diphencyprone Induced Vitiligo: A Case Report

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Mohammad Ali Nilforoushzadeh ◽  
Gelavizh Keshtmand ◽  
Fariba Jaffary ◽  
Abbas Kheirkhah
Keyword(s):  
Adverse Effect ◽  
Case Report ◽  
Family History ◽  
Hair Loss ◽  
Direct Role ◽  
Positive Patch Test ◽  
Remote Areas ◽  
History Of ◽  
Dermatological Disorders

Diphencyprone (DCP) is a contact sensitizer which is used to treat dermatological disorders with an immunological origin, such as extensive alopecia areata (AA). Vitiligo is a rare but known side effect of DPCP therapy which is formed in the treatment site or remote areas. In this paper a 37-year-old man developed alopecia totalis with loss of eyebrows and eyelashes who presented some vitiligo patches on his scalp and arm distant from the location of DPCP application and a 42-year-old woman with 25 years history of hair loss and 3 months DPCP application who revealed some vitiligo patches on the scalp with distant to the site of application at the 6th week are reported. Considering the absence of personal and family history of Vitiligo in our two cases, the hypothesis of latent Vitiligo is not proved. The positive patch test in left arm of one of the patients also suggests the direct role of DPCP as the cause of Vitiligo occurrence. As the development of vitiligo by DCP is unpredictable and the depigmentation may persist indefinitely, it is important to inform all patients about this potential adverse effect before starting the treatment.

The current role of laser/light sources in the treatment of male and female pattern hair loss

2007 ◽  
Vol 9 (1) ◽  
pp. 27-28 ◽  
Author(s):  
Marc R. Avram ◽  
Robert T. Leonard ◽  
Edwin S. Epstein ◽  
Joseph L. Williams ◽  
Alan J. Bauman
Keyword(s):  
Hair Loss ◽  
Laser Light ◽  
Light Sources ◽  
Male And Female ◽  
Current Role ◽  
Female Pattern Hair Loss

scholarly journals Evaluation of trichoscopic features in female pattern hair loss

2021 ◽  
Vol 7 (4) ◽  
pp. 284-287
Author(s):  
Somya Agrawal ◽  
Krishnendra Varma ◽  
Ujjwal Kumar ◽  
Aishwarya Mahadik
Keyword(s):  
Clinical Examination ◽  
Hair Loss ◽  
Definitive Diagnosis ◽  
Exclusion Criteria ◽  
Detailed History ◽  
Non Invasive ◽  
Female Pattern Hair Loss ◽  
Hair Fiber ◽  
Hair Diameter

Female pattern hair loss (FPHL) is explained by decrease in hair fiber production and their eventual miniaturization. It is considered a counterpart of male androgenetic alopecia but the role of androgens in its pathogenesis is yet to be proven. To evaluate the trichoscopic features in females with patterned hair loss. Inclusion and exclusion criteria were applied and 37 cases were enrolled in our study. Detailed history and clinical examination were done to establish the diagnosis. Trichoscopic examination was done after taking consent in diagnosed cases. On trichoscopy, hair diameter variability, peri pilar sign, white dots, scalp pigmentation and focal atrichia was observed in 62.2%, 62.2%, 40.5%, 45.9% and 40.5% respectively. Most common trichoscopy finding observed was peri pilar sign and hair diameter variability in 23/37 females. Definitive diagnosis of FPHL is difficult to be established solely on the basis of clinical examination. Thus, trichoscopy serves as a non-invasive tool to ascertain the diagnosis in these patients.

scholarly journals Managing patterned hair loss – a hair raising task!

2021 ◽  
Vol 1 ◽  
pp. 55
Author(s):  
Aseem Sharma ◽  
Manasi Shirolikar ◽  
Madhulika Mhatre
Keyword(s):  
Hair Loss ◽  
Clinical Presentation ◽  
Short Review ◽  
Population Based ◽  
Androgenetic Alopecia ◽  
Psychosocial Burden ◽  
Weighted Averages ◽  
Female Pattern Hair Loss ◽  
Topical Minoxidil

Diffuse alopecia wields a significant psychosocial burden by virtue of its clinical presentation and visibility. Patterned alopecia is an umbrella term with the focus point being androgen-mediated alopecias - androgenetic alopecia/male pattern baldness/male androgenetic alopecia and female pattern hair loss/female androgenetic alopecia, both of which have a genetic susceptibility that alters the follicular sensitivity to circulating androgens. Diffuse alopecia affects nearly half the population based on weighted averages. It may present with hair shedding and hair thinning (miniaturization) or a combination. With the female variant, the role of androgens is not fully delineated; hence, the term female pattern hair loss which has replaced prior nomenclature. Managing patterned hair loss has seen a sea change in the last decade, moving well beyond the FDA-approved modalities - topical minoxidil and oral finasteride. Through this short review, the authors have attempted to condense existing information into a ready reference.

scholarly journals 193 Unveiling the role of estradiol in the pathogenesis of female pattern hair loss

2016 ◽  
Vol 136 (9) ◽  
pp. S194
Author(s):  
M. Takahashi ◽  
Y. Endo ◽  
Y. Obayashi ◽  
T. Serizawa ◽  
M. Murakoshi ◽  
...  
Keyword(s):  
Hair Loss ◽  
Female Pattern Hair Loss

scholarly journals The role of photobiomodulation when associated with microneedling in female pattern hair loss

Medicine ◽  
2019 ◽  
Vol 98 (12) ◽  
pp. e14938 ◽  
Author(s):  
Suzana Polonca da Silveira ◽  
Sandra Rojas Urquizas Moita ◽  
Silvia Vicente da Silva ◽  
Maria Fernanda Setúbal Destro Rodrigues ◽  
Daniela de Fátima Teixeira da Silva ◽  
...  
Keyword(s):  
Hair Loss ◽  
Female Pattern Hair Loss

scholarly journals Clinical Characteristics of Female Patterned Hair Loss in Patients Attending Hair Clinic in Thailand

2022 ◽  
Vol 74 (1) ◽  
pp. 19-26
Author(s):  
Warayuwadee Amornpinyo ◽  
Rattapon Thuangtong ◽  
Supisara Wongdama ◽  
Daranporn Triwongwaranat
Keyword(s):  
Family History ◽  
Hair Loss ◽  
Age Of Onset ◽  
Ferritin Level ◽  
Demographic Data ◽  
Positive Family History ◽  
Premenopausal Women ◽  
Female Pattern Hair Loss ◽  
Menopausal Women ◽  
History Of

Objective: To study the clinical features and associated factors of female pattern hair loss (FPHL) in premenopausal and menopausal women patients. Materials and Methods: This is a retrospective chart review of FPHL patients visited hair clinic, Siriraj Hospital from June 2012 to May 2015. Demographic data, family history and history of hair loss were evaluated. Factors associated with FPHL were analysed. Results: There were 267 patients (180 premenopausal women and 87 menopausal women) in this study. The mean age of onset of patients was 35.5±12 years (premenopausal FPHL) and 60.5±7 years (menopausal FPHL). Positive family history of androgenetic alopecia (AGA) was 48.3%, mainly in first-degree relatives. The data showed an increased incidence of FPHL with advancing age. The most common presentation is Ludwig grade I. The study showed that patients also have dyslipidemia (16.9%), hypertension (16.5%), diabetes mellitus (10.9%), hypothyroidism (4.9%), anemia (3.7%), and hyperthyroidism (2.9%). In multivariate analysis, significant associations were found between low ferritin level < 70 µg/L and premenopausal FPHL (OR 5.51, 95% CI 2.26-15.14, P = 0.01). Conclusion: Maternal family history of AGA seems to have a greater influence on premenopausal FPHL. Low serum ferritin levels < 70 µg/L were significantly associated with FPHL in premenopausal women.

Sign in / Sign up

Export Citation Format

Share Document